Drug Price Wars: What Can Really Tame Big Pharma?

10/14/2025 Ineteconomics Analysis

Here’s the breakdown on what’s really driving America’s runaway drug prices -- and whether any of the current plans stand a chance to lower your pharmacy bill.
When it comes to the sickening cost of prescription drugs in America, this much is true: Big Pharma didn’t get rich by playing nice. It got rich playing Wall Street games.

For decades, economist William Lazonick has been exposing how Pharma’s Wall Street-driven business model doesn’t just lead to sky-high drug prices, but actually stifles innovation, too.

How this year’s Nobel winners changed the thinking on economic growth

10/14/2025 The Conversation UK

The prizewinners were announced at a ceremony in Stockholm. EPA/ANDERS WIKLUND SWEDEN OUTWhat makes some countries rich and others poor? Is there any action a country can take to improve living standards for its citizens? Economists have wondered about this for centuries. If the answer to the second question is yes, then the impact on people’s lives could be staggering.

Decomposing US economic fluctuations: a trend-cycle approach

10/14/2025 European Central Bank Central banks

This paper proposes a unified framework to study the permanent and transitory origins of US economic fluctuations. The model provides a reasonable account of the evolution of the economy in the post-war period and of the recent inflation episode. Overall, it constitutes a comprehensive framework to offer policy guidance and a flexible empirical counterpart to more heavily-parametrized structural models.

Decomposing US economic fluctuations: a trend-cycle approach

10/14/2025 European Central Bank Central banks

This paper proposes a unified framework to study the permanent and transitory origins of US economic fluctuations. The model provides a reasonable account of the evolution of the economy in the post-war period and of the recent inflation episode. Overall, it constitutes a comprehensive framework to offer policy guidance and a flexible empirical counterpart to more heavily-parametrized structural models.

Pages

Subscribe to Front page feed